Something really exciting happened and we just had to share it with all of you. Dr. Nivedita and Dr. Nandini Dadu have been featured in The New York Times. For those who don't know, The New York Times is one of the most read and respected newspapers in the entire world so this is genuinely a big deal and we are so proud.
- So what is the article about?
The New York Times published a piece on March 19, 2026 around a topic that is very close to home for a lot of our patients Ozempic and Wegovy. These are the medicines most of you have heard about by now, the ones that have completely changed how the world looks at weight loss and diabetes management. The article talks about how the patents on these drugs are now expiring in countries like India, China, Canada and Brazil. What that basically means is that cheaper, generic versions of these medicines are going to start becoming available very soon. For Indian patients especially, this is huge news. These medicines were always effective but the cost kept them out of reach for most people. That is now about to change, and the article does a great job of explaining what this shift looks like and what it means for patients around the world.
- Why does this matter to us?
Because Dr. Nivedita and Dr. Nandini Dadu have been talking about exactly this for a long time now. Long before Ozempic became a buzzword on social media, they were studying these treatments, understanding them, and carefully using them to help patients here. They never jumped on trends; they did the work. And now The New York Times has taken notice.
Getting featured in a publication like this does not happen by accident. It happens because of years of showing up for patients, staying updated with global research, and having something genuinely useful to say. That is exactly what both doctors bring to the table every single day.
For our patients, this is also a reminder that the care you are receiving here is not behind the times it is part of the global conversation. The questions you ask in your appointments, the treatments being discussed, the concerns about cost and access all of that is being talked about at the highest levels, and your doctors are right there in the middle of it.
We really encourage you to read the full article. Whether you are someone managing your weight, dealing with diabetes, or just someone curious about where medicine is headed this piece will give you a lot to think about. And if anything in it raises questions for you personally, you know where to find us. Dr. Nivedita and Dr. Nandini Dadu are always happy to sit down and talk through what any of this means for your specific health journey.
Share this with your family and friends too, especially anyone who has been looking at semaglutide or asking about newer options for weight or diabetes management. This might be exactly the read they needed.
Ref. nytimes.com